Biological Markers for the Diagnosis of Central Nervous System Infective Diseases

NCT02278016 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2016-01-01

No results posted yet for this study

Summary

Bacterial meningitis is a potentially life-threatening disease that is associated with substantial neurological morbidity and mortality. Accurate diagnosis is essential to improve outcome and prevent antibiotic overuse. Here we try to explore new biological markers for the diagnosis of the central nervous system infection disease.

Conditions

Sponsors & Collaborators

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • jiang wen, MD · The Department of Neurology , Xijing Hospital

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2016-07-31
Completion
2017-07-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02278016 on ClinicalTrials.gov